Dilution of Existing Shareholders Through the Exercise of Stock Acquisition Rights
First written in FY2021. 5 of 10 entries say "Materialised", first in FY2022-Q2. Latest entry: FY2026-H1.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- FY2026-H1MaterialisedAnnual report
「Note: The increase resulted from the exercise of stock acquisition rights.」
Exercise of stock acquisition rights increased issued shares by 60,000 from January to June 2026, realizing the dilution factor as an increase in shares outstanding. - FY2025RestatedAnnual report
「As of the end of the month preceding the filing date, February 2026, the number of potential shares represented by these stock options was 1,087,200, equivalent to 9.4% of the total number of issued shares including potential shares, which was 11,534,500.」
Despite an increase of 118,000 common shares through exercises in 2025 and the issuance of 129,000 shares under the 14th series, potential dilution was 9.4% at the end of the month preceding the filing date. - FY2024-H1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Exercise of stock acquisition rights increased issued shares by 2,000 from January to June 2024, bringing the total to 10,109,300 at the end of June. - FY2024-Q1WorsenedAnnual report
「Number of stock acquisition rights (units): 3,220」
On 19 April 2024, the company issued 3,220 13th-series stock acquisition rights covering 322,000 shares, adding to potential dilution exposure. - FY2023WorsenedAnnual report
「As of the end of the month preceding the filing date, February 2024, the number of potential shares represented by these stock options was 1,058,200, equivalent to 9.5% of the total number of issued shares including potential shares, which was 11,165,500.」
The company disclosed potential shares and a potential dilution ratio of 9.5%, up from 7.9% at FY2021. - FY2023-Q3MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Exercise of stock acquisition rights increased issued shares by 202,000 from July to September 2023, bringing the total to 10,103,300 as of 30 September 2023. - FY2023-Q1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Exercise of stock acquisition rights increased issued shares by 66,000 from January to March 2023, bringing the total to 9,901,300 as of 31 March 2023. - FY2022-Q2MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
Exercise of the 11th series increased issued shares by 30,000 to 9,833,300. Stock acquisition rights covering 531,200 potential shares remained outstanding. - FY2022-Q1WorsenedAnnual report
「Number of shares underlying stock acquisition rights (shares): 531,200」
The issuance of the 11th series of stock acquisition rights was approved, covering 531,200 underlying shares. Exercise conditions included revenue targets for the fiscal years ending December 2023 through December 2025, but this filing did not disclose the percentage represented by all potential shares. - FY2021First statedAnnual report
「As of the filing date, the number of potential shares represented by these stock options was 822,000, equivalent to 7.9% of the total number of issued shares including potential shares, which was 10,438,000.」
The company discloses the possibility that exercise of stock options could dilute share value and voting percentages.